Written by The global Coronary Stents Market is witnessing steady growth due to the increasing prevalence of cardiovascular diseases, rising cases of coronary artery disease, and growing demand for advanced cardiac treatments. Coronary stents are small medical devices placed inside narrowed or blocked arteries to restore blood flow and support heart health. Increasing numbers of percutaneous coronary intervention (PCI) procedures, an aging population, and improvements in minimally invasive cardiac treatments are contributing to market expansion. According to Market Research Future, the market was valued at USD 8.92 billion in 2025 and is projected to reach USD 14.26 billion by 2035, growing at a CAGR of 4.80% during the forecast period of 2026–2035.
Technological advancements in drug-eluting stents, bioresorbable vascular scaffolds, and advanced stent materials are creating new growth opportunities for industry participants. The market is segmented into drug-eluting stents, bare-metal stents, and bioresorbable vascular scaffolds, with applications across hospitals, cardiac centers, and ambulatory surgical centers. Leading companies, including Abbott Laboratories, Boston Scientific, Medtronic, Terumo Corporation, and B. Braun Melsungen, are focusing on product innovation, research and development, and strategic collaborations to strengthen their market positions. Furthermore, expanding healthcare infrastructure, increasing investments in cardiovascular care, and rising adoption of advanced cardiac technologies are expected to support market growth, particularly across emerging economies in Asia-Pacific.
Frequently Asked Questions (FAQs)
Q1. What is the projected size of the Coronary Stents Market by 2035?
The global Coronary Stents Market is projected to reach USD 14.26 billion by 2035.
Q2. What is the expected CAGR of the Coronary Stents Market?
The market is expected to register a CAGR of 4.80% during the forecast period of 2026–2035.
Q3. What are the major factors driving the Coronary Stents Market?
The increasing prevalence of cardiovascular diseases, rising coronary artery disease cases, growing surgical procedures, and technological advancements in stent products are major growth drivers.
Q4. Who are the key players in the Coronary Stents Market?
Major companies include Abbott Laboratories, Boston Scientific, Medtronic, Terumo Corporation, and B. Braun Melsungen.
Q5. Which region is expected to witness significant growth in the Coronary Stents Market?
Asia-Pacific is expected to witness significant growth due to expanding healthcare infrastructure, increasing cardiovascular disease awareness, and rising investments in advanced cardiac treatment facilities.
Access detailed findings to navigate market complexities:
Veterinary/Animal Healthcare Market Growth
Small Molecules Innovator CDMO Market Demand